Unlock instant, AI-driven research and patent intelligence for your innovation.

Method for manufacturing body substitutes by additive deposition

A substitute and addition technology, applied in the field of body tissue substitutes, the manufacture of body substitutes, and the substitutes of skin tissue, which can solve the problems of no solution, no natural epidermal layered structure, etc.

Inactive Publication Date: 2018-10-23
皮肤替代研究实验室 +4
View PDF21 Cites 4 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, the skin substitute thus obtained does not have the layered structure of the natural epidermis, and it contains many pores
[0019] Currently, there is no solution to the problem of using additive techniques to create skin substitutes with sufficient structural and functional similarity to natural skin

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Method for manufacturing body substitutes by additive deposition
  • Method for manufacturing body substitutes by additive deposition
  • Method for manufacturing body substitutes by additive deposition

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0117] Example 1 : Cell culture and collection

[0118] This example illustrates a method for expanding and harvesting cells (fibroblasts and keratinocytes) which can then be used to manufacture a skin substitute according to the invention.

[0119] Skin keratinocytes and fibroblasts isolated from human foreskin.

[0120] Keratinocytes were cultured on human fibroblasts irradiated using techniques well known to those skilled in the art using a medium known as "Green's medium" containing DMEM and Ham's F12 (in a 3:1 ratio), Add adenine (24.3 μg / mL) and human epidermal growth factor (10 ng / mL), hydrocortisone (0.4 μg / mL), insulin ( 5μg / mL), 2×10 -9 M's triiodo-L-thyronine (5 μg / mL), 10 -10 M isoproterenol, penicillin (100 U / mL), streptomycin (100 μg / mL) and 10% fetal bovine serum. Keratinocytes collected during passages 2, 3 and 4 were used.

[0121] 5% CO at 37°C 2 Fibroblasts were cultured in an appropriate medium containing DMEM, 20% newborn calf serum and antibiotic...

Embodiment 2

[0122] Example 2 : deposited by additive techniques (method according to the invention)

[0123] A first aqueous solution of gelatin was prepared by dissolving gelatin powder at 20% m / v in 0.9% m / v NaCl solution. A second aqueous solution of alginate was prepared by dissolving alginate powder (very low viscosity) at 4% m / v in 0.9% m / v NaCl solution. A third aqueous solution of 8% m / v fibrinogen was prepared, to which was added the fibroblast suspension (obtained in Example 1) at a cell concentration of 2 million cells / mL.

[0124] These three solutions are then mixed to obtain a mixture (called "bioink") comprising 50% by volume of the first solution (gelatin), 25% by volume of the second solution (alginate) and 25% by volume of the second solution (alginate). Trisolution (fibroblasts recovered in fibrinogen).

[0125] Prepare an aqueous polymerization solution containing 3% m / v calcium and thrombin at a final concentration of 20 U / mL.

[0126] The bioink has a viscosity ...

Embodiment 3

[0128] Example 3 : maturation of skin substitute precursors (method according to the invention)

[0129] The skin substitute precursors were cultured for 12 days in fibroblast medium containing 1 mM ascorbic acid 2-phosphate; the skin substitute precursors were nourished daily. Twelve days later, the keratinocytes were 2 2.5×10 5 A concentration of 300 cells is coated on the surface of the skin substitute precursor.

[0130] The skin substitute precursor was cultured for the first seven-day culture period by immersion in Green's medium with ascorbic acid 2-phosphate and antibiotics at a concentration of 1 mM, as described above; the skin substitute precursor was nourished daily .

[0131] The skin substitute precursors were then cultured for a second 21-day culture period by maintaining them at the liquid surface in differentiation medium containing DMEM with hydrocortisone (0.4 μg / mL), insulin (5 μg / mL), ascorbic acid 2-phosphate and antibiotics; differentiation mediu...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to a method for manufacturing a bio-ink by additive deposition. The method comprises supplying: a first solution including between 5 and 40 wt.% gelatin; a second solution including between 15 and 35.wt.% alginate; a third solution including between 1 and 15 wt.% fibrinogen, and optionally living cells in suspension; and creating a mixture including: around 35 to 65 vol.% ofthe first solution; around 15 to 35 vol.% of the second solution; and around 15 to 35 vol.% of the third solution, said proportions being selected so that they add up to 100%. Said bio-ink allows theadditive deposition of objects that can be polymerised by means of a solution including calcium ions and thrombin. Said objects can be incubated and can be used as a substitute for body tissue, for example (with added fibroblasts) as skin substitute.

Description

technical field [0001] The present invention relates to the field of biotechnology, more specifically to body tissue substitutes, especially skin tissue substitutes. In particular, the invention relates to the manufacture of bodily (such as skin) substitutes intended to be implanted in the body or to be tested for active ingredients of pharmaceuticals or cosmetics in order to evaluate their toxicity, efficacy or presence in bodily tissues. Penetration. Background technique [0002] In Europe, chemical products used in cosmetics can no longer be tested on laboratory animals; therefore, there are constant attempts to: improve skin substitutes, give skin substitutes characteristics closer to those of natural skin, reduce skin substitutes production and use costs. Among the different experimental methods for fabricating biotechnological materials and substrates, additive deposition has received considerable attention in the past few years. [0003] Additive manufacturing meth...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C12N5/071A61K35/36C12Q1/02B33Y80/00
CPCC12N2500/38C12N2501/11C12N2501/33C12N2501/39C12N2501/395C12N2501/805C12N2502/091C12N2502/092C12N2502/094C12N2502/097C12N2502/1305C12N2502/1323C12N2503/06C12N2533/52C12N2533/54C12N2533/56C12N2533/74B33Y80/00B33Y70/00G01N33/50C12N5/0698C12N5/0602A61L27/3604B33Y40/10B33Y10/00A61L27/3843C12N5/0629C12N5/0656C12N2533/30
Inventor 克里斯托夫·马凯特莱娅·宝榭阿梅利·泰波摩根·多斯·桑托斯
Owner 皮肤替代研究实验室